Corvus Pharmaceuticals, Inc.
CRVS
Revenue
0.00
0.000.00%
-Assets
64.56M
▲24.48M▲61.06%
3 Months ChangeLiabilities
13.34M
▲6.62M▲98.44%
3 Months ChangeFree Cash Flow
-8.15M
▲861.00k▲9.56%
48 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0001558370-24-013518
2024-08-06
Form 10-Q
ID: 0001558370-24-011076
2024-08-06
Form 8-K
ID: 0001171843-24-004479
2024-06-14
Form 8-K
ID: 0001171843-24-003444
2024-05-07
Form 10-Q
ID: 0001558370-24-007093
2024-05-06
Form 8-K
ID: 0001193125-24-131920
2024-05-06
Form 8-K
ID: 0001171843-24-002569
2024-05-01
Form 8-K
ID: 0001193125-24-127611
2024-03-19
Form 8-K
ID: 0001171843-24-001454
2024-01-23
Form 8-K
ID: 0001171843-24-000360